Theratechnologies (THTX) News Today $2.60 +0.05 (+1.76%) As of 03:08 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock THTX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Theratechnologies (NASDAQ:THTX) Trading Up 0.5% - Here's WhyTheratechnologies (NASDAQ:THTX) Trading 0.5% Higher - Still a Buy?May 10, 2025 | marketbeat.comTheratechnologies (NASDAQ:THTX) Trading Up 0.5% - Here's What HappenedTheratechnologies (NASDAQ:THTX) Trading Up 0.5% - Time to Buy?May 10, 2025 | marketbeat.comTheratechnologies announces annual shareholder meetingMay 4, 2025 | uk.investing.comTheratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIVMay 2, 2025 | globenewswire.comTheratechnologies: A High-Risk, High-Reward Speculation As Shares Trade At 39% Discount To Future Pak's $3.51-$4.50 OfferApril 18, 2025 | seekingalpha.comIs Theratechnologies Inc. (THTX) the Best Rising Penny Stock to Buy According to Analysts?April 18, 2025 | msn.comResearch Analysts Set Expectations for THTX FY2025 EarningsTheratechnologies Inc. (NASDAQ:THTX - Free Report) - Equities researchers at Leede Financial reduced their FY2025 earnings per share estimates for shares of Theratechnologies in a research note issued on Monday, April 14th. Leede Financial analyst D. Loe now forecasts that the company will post eApril 18, 2025 | marketbeat.comWhat is Leede Financial's Estimate for THTX FY2026 Earnings?Theratechnologies Inc. (NASDAQ:THTX - Free Report) - Leede Financial reduced their FY2026 earnings estimates for shares of Theratechnologies in a research report issued to clients and investors on Monday, April 14th. Leede Financial analyst D. Loe now forecasts that the company will earn $0.12 peApril 17, 2025 | marketbeat.comShort Interest in Theratechnologies Inc. (NASDAQ:THTX) Rises By 2,740.1%Theratechnologies Inc. (NASDAQ:THTX - Get Free Report) saw a significant increase in short interest in March. As of March 31st, there was short interest totalling 1,190,000 shares, an increase of 2,740.1% from the March 15th total of 41,900 shares. Based on an average daily trading volume, of 1,030,000 shares, the short-interest ratio is presently 1.2 days. Approximately 6.2% of the shares of the stock are short sold.April 16, 2025 | marketbeat.comTheratechnologies to further evaluate potential sale of the companyApril 16, 2025 | markets.businessinsider.comTheratechnologies Provides Update on Sale ProcessApril 15, 2025 | financialpost.comTheratechnologies Provides Update on Sale ProcessApril 15, 2025 | globenewswire.comTheratechnologies Engages in Exclusive Acquisition TalksApril 15, 2025 | tipranks.comSoleus Capital Issues Letter to The Board of TheratechnologiesApril 12, 2025 | financialpost.comSoleus Capital Issues Letter to The Board of TheratechnologiesApril 12, 2025 | businesswire.comTheratechnologies Responds to Future Pak's Press Release and Announces Exclusive Discussions with Another Potential Acquiror for the Sale of the CompanyApril 11, 2025 | globenewswire.comFuture Pak submits proposals to acquire TheratechnologiesApril 11, 2025 | msn.comFuture Pak Submits Proposals to Acquire Theratechnologies Inc. ...April 11, 2025 | gurufocus.comFuture Pak Submits Proposals to Acquire Theratechnologies Inc., Offering up to $255 Million in Total ValueApril 11, 2025 | businesswire.comTheratechnologies Stock Plummets On Disappointing Q1 Earnings, Full Year Forecast: Retail Sentiment SoursApril 9, 2025 | msn.comTheratechnologies Reports Financial Results for the First Quarter 2025 and Reviews Key AchievementsApril 9, 2025 | globenewswire.comTheratechnologies Reports Financial Results for the First Quarter 2025 and Reviews Key AchievementsApril 9, 2025 | globenewswire.comTheratechnologies receives FDA approval of PAS for EGRIFTA SV sBLAApril 8, 2025 | markets.businessinsider.com3THTX : Examining the Future: Theratechnologies's Earnings OutlookApril 8, 2025 | benzinga.comTheratechnologies Receives FDA Approval of Prior Approval Supplement (PAS) for EGRIFTA SV® sBLAApril 8, 2025 | financialpost.comTheratechnologies Inc. (NASDAQ:THTX) Short Interest Down 13.6% in MarchTheratechnologies Inc. (NASDAQ:THTX - Get Free Report) saw a large decrease in short interest in the month of March. As of March 15th, there was short interest totalling 41,900 shares, a decrease of 13.6% from the February 28th total of 48,500 shares. Based on an average daily volume of 199,200 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.2% of the company's shares are sold short.April 4, 2025 | marketbeat.comTheratechnologies to Announce First Quarter 2025 Financial Results and Provide Business UpdateApril 3, 2025 | globenewswire.comAIGH Capital Management LLC Sells 698,635 Shares of Theratechnologies Inc. (NASDAQ:THTX)AIGH Capital Management LLC reduced its position in Theratechnologies Inc. (NASDAQ:THTX - Free Report) by 18.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 3,026,569 shares of the company's stock after selling 698,635 shares during the period. TheMarch 31, 2025 | marketbeat.comTheratechnologies rises after FDA label expansion for best seller EgriftaMarch 26, 2025 | msn.comTheratechnologies Receives FDA Approval for EGRIFTA WR (Tesamorelin F8) to Treat Excess Visceral Abdominal Fat in Adults with HIV and LipodystrophyMarch 26, 2025 | finanznachrichten.deTheratechnologies Receives FDA Approval for EGRIFTA WR™ (Tesamorelin F8) to Treat Excess Visceral Abdominal Fat in Adults with HIV and LipodystrophyMarch 25, 2025 | financialpost.comTheratechnologies Receives FDA Approval for EGRIFTA WR™ (Tesamorelin F8) to Treat Excess Visceral Abdominal Fat in Adults with HIV and LipodystrophyMarch 25, 2025 | globenewswire.comTheratechnologies Reports Encouraging Results From PROMISE-US Trial Of IbalizumabMarch 14, 2025 | nasdaq.comTheratechnologies presents data on limitations of using BMI to assess CV riskMarch 12, 2025 | markets.businessinsider.comTheratechnologies CROI Presentation Highlights Limitations of Using BMI to Assess Cardiovascular (CV) Risk in People with HIVMarch 12, 2025 | financialpost.comTheratechnologies CROI Presentation Highlights Limitations of Using BMI to Assess Cardiovascular (CV) Risk in People with HIVMarch 12, 2025 | globenewswire.comTheratechnologies Presents Encouraging Virologic Suppression Data from the PROMISE-US Trial of Ibalizumab at CROIMarch 12, 2025 | globenewswire.comJonesTrading Reaffirms Their Hold Rating on Theratechnologies (THTX)March 5, 2025 | markets.businessinsider.comWhat is Leede Financial's Forecast for THTX FY2027 Earnings?Theratechnologies Inc. (NASDAQ:THTX - Free Report) - Leede Financial issued their FY2027 EPS estimates for Theratechnologies in a report issued on Wednesday, February 26th. Leede Financial analyst D. Loe expects that the company will post earnings of $0.23 per share for the year. The consensus esMarch 1, 2025 | marketbeat.comTheratechnologies Inc. (NASDAQ:THTX) Short Interest Up 212.7% in FebruaryTheratechnologies Inc. (NASDAQ:THTX - Get Free Report) was the target of a large growth in short interest during the month of February. As of February 15th, there was short interest totalling 31,900 shares, a growth of 212.7% from the January 31st total of 10,200 shares. Currently, 0.2% of the shares of the company are short sold. Based on an average daily volume of 123,000 shares, the short-interest ratio is currently 0.3 days.February 28, 2025 | marketbeat.comWhat is Leede Financial's Estimate for THTX FY2025 Earnings?Theratechnologies Inc. (NASDAQ:THTX - Free Report) - Research analysts at Leede Financial lowered their FY2025 earnings estimates for shares of Theratechnologies in a research report issued to clients and investors on Wednesday, February 26th. Leede Financial analyst D. Loe now expects that the cFebruary 27, 2025 | marketbeat.comTheratechnologies Inc. (THTX) Q4 2024 Earnings Call TranscriptFebruary 26, 2025 | seekingalpha.comTheratechnologies (NASDAQ:THTX) Posts Earnings ResultsTheratechnologies (NASDAQ:THTX - Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by ($0.14).February 26, 2025 | marketbeat.comTheratechnologies (NASDAQ:THTX) Announces Quarterly Earnings Results, Misses Expectations By $0.14 EPSTheratechnologies (NASDAQ:THTX - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of $0.05 by ($0.14).February 26, 2025 | marketbeat.comTheratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2024February 26, 2025 | globenewswire.comTheratechnologies upgraded to Buy from Speculative Buy at Mackie ResearchFebruary 14, 2025 | markets.businessinsider.comTheratechnologies to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business UpdateFebruary 14, 2025 | globenewswire.comTheratechnologies to resume distribution of EGRIFTAFebruary 14, 2025 | markets.businessinsider.comTheratechnologies Resumes Distribution of EGRIFTA SV®February 13, 2025 | financialpost.comTheratechnologies Resumes Distribution of EGRIFTA SV®February 13, 2025 | financialpost.com Get Theratechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for THTX and its competitors with MarketBeat's FREE daily newsletter. Email Address THTX Media Mentions By Week THTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. THTX News Sentiment▼0.000.65▲Average Medical News Sentiment THTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. THTX Articles This Week▼02▲THTX Articles Average Week Get Theratechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for THTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AMLX News Today ARVN News Today DNA News Today ALT News Today SAGE News Today CGEM News Today SEPN News Today TECX News Today SIGA News Today TRML News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:THTX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theratechnologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Theratechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy THTX Stock Free THTX Stock Alerts